Neoplasms

3,880 trials 1,551 recruiting

Filter these 3,880 trials by phase, country and sponsor.

Open in Search →

BeCALM - Brentuximab vedotin in CutAneous T-cell Lymphomas (CTCL): post-allogeneic hematopoietic stem cell transplant Maintenance Pending

2025-521093-34-00 rare disease 5
Treatment of Warthin’s tumor: schlerotherapy and its natural course Pending

2024-518794-33-00 Warthin's tumor 6
A Phase 1/2a Study of BMS-986523 as Monotherapy and in Combination with Anti-cancer Agents in Participants with Advanced Solid Malignancies Pending

2025-523547-35-00 Advanced Solid Tumor Malignancies 7
A phase 1/2 study of subcutaneous blinatumomab administration in children with R/R and MRD+ B-ALL Pending

2025-521671-31-00 Relapsed/Refractory (R/R) and Minimal Residual Disease 9
A study of BMS-986504 as Monotherapy and in Combination with Other Agents in Participants with Advanced and/or Metastatic Solid Tumors with … Pending

2025-524285-18-00 Advanced and/or Metastatic Solid Tumors with Homozygous 4
Progression under Olaparib: a randomized phaSE II trIal with docetaxel or carboplatin-docetaxel DOublet in mCRPC patieNts Pending

2023-503676-25-01 prostate cancer 4
PROSPECTIVE RANDOMISED CLINICAL TRIAL TO EVALUATE THE EARLY RECURRENCE RATE IN NON-MUSCLE INVASIVE BLADDER CANCER BETWEEN THE USE OF CHEMOHY… Pending

2024-519890-21-00 Non-muscle invasive bladder cancer 11
An adaptive open-label multicentre phase 1/2 trial, to determine the recommended phase 2 dose of CCTx-001, and to assess safety, tolerabilit… Pending

2023-506865-71-00 Relapsed/Refractory Acute Myeloid Leukemia (AML) 7
A Phase 1/2, First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Anti_Tumor Activity of AVZO-02… Pending

2024-517339-30-00 Advanced Solid Tumors 7
A multicenter open-label phase II study of Cemiplimab plus chemotherapy, selected on the basis of baseline cytidine deaminase activity, in a… Pending

2024-517799-40-00 Advanced squamous non-small cell lung cancer 4
A study of pelabresib and ruxolitinib compared to placebo and ruxolitinib in adult patients with myelofibrosis who have not received prior t… Pending

2025-523555-66-00 Myelofibrosis 5
FLuorescent Assisted Surgery for Head and neck cancer: Perioperative Optical Imaging in Neck dissection and Transoral robotic surgery (FLASH… Pending

2025-522845-23-00 Oral Squamous Cell Carcinoma with neck metastases 4
First study evaluating the safety and dosage of YG-01 in patients with a malignant brain tumor Pending

2025-524299-44-00 Glioblastoma 1
A short treatment with immunotherapy instead of radiotherapy in early-stage lung cancer Pending

2025-524305-32-00 Stage I non-small cell lung cancer 4
An open-label phase 2/3 study to analyse the feasibility and evaluate the safety of intravenous administration of 99mTc-PSMA-T4 in patients … Pending

2024-519358-35-00 Feasibility analysis and safety evaluation of [99mTc]Tc 10
A Study of Vepugratinib (LY3866288) in Participants with Cancer in the Urinary Tract ( FORAGER-2 ) Pending

2025-522855-25-00 Urinary Bladder Neoplasms 5
A Phase II, Open-Label Randomized Study of Intravenous Tambiciclib in Combination with the Standard of care Venetoclax and Azacitidine in Pa… Pending

2025-524308-31-00 Acute myeloid leukemia 4
A phase IIa, single-arm, single-center, open label, proof-of-concept trial evaluating increased frequency dosing of VCN-01 (zabilugene almad… Pending

2026-525566-21-00 metastatic pancreatic adecarcinoma 4
APECS II: Comparing the efficacy of Pectoral Nerve (PECS II) Block with long-acting liposomal bupivacaine versus levobupivacaine for Mastect… Pending

2024-515183-30-00 Postoperative and chronic pain after breast cancer surg 5
Phase II study of ezabenlimab in patients with PD-L1-positive head and neck cancer with residual disease detected by ctDNA after chemoradiot… Pending

2025-523575-36-00 Locally advanced head and neck squamous cell carcinoma 4
Evaluate the efficacy of 12-month neoadjuvant chemotherapy in terms of disease-free survival in patients with localized digestive neuroendoc… Pending

2024-515603-19-01 Localized digestive Neuroendocrine Carcinomas 4
Lantiolihaspuudutuksen vaikutus munuaisen poistoleikkauksen jälkeiseen kivun hoitoon ja toipumiseen Pending

2024-519910-30-00 Renal cancer 6
Safety and efficacy of treatment combination with ponatinib and asciminib in chronic myeloid leukemia patients resistant to ponatinib and/or… Pending

2025-521126-15-00 Chronic Myeloid Leukemia 4
The impact of PDD during TURB for NMIBC: a prospective randomized controlled trial Pending

2024-514316-27-00 Not muscular invasive bladder cancer 6